Join us for a conversation with Kiran Avancha, co-founder of priZm Therapeutics, as he shares his journey developing breakthrough therapies for ultra-rare pediatric diseases. Learn how priZm’s lead program, SRW101, is advancing treatment for AHDS and what it takes to build a mission-driven biotech from the ground up.

Tuesday, August 19, 2025

8:00 am - 9:00 am AZ/PDT

on Zoom